OCUL’s Stochastic Averages Dip: Analyzing Ocular Therapeutix Inc’s Stock Performance

The market performance of Ocular Therapeutix Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $7.96 on 06/12/23, with the lowest value for the same timeframe being $2.00, recorded on 11/10/23.

52-week price history of OCUL Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Ocular Therapeutix Inc’s current trading price is -28.64% away from its 52-week high, while its distance from the 52-week low is 184.71%. The stock’s price range during this period has fluctuated between $2.00 and $7.96. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.33 for the day, which was evidently lower than the average daily volume of 2.77 over the last three months.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Financial Performance and Market Capitalization

Ocular Therapeutix Inc (OCUL) has experienced a quarterly rise of 130.43% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 626.05M.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.45, with a change in price of +2.36. Similarly, Ocular Therapeutix Inc recorded 1,182,155 in trading volume during the last 100 days, posting a change of +71.08%.

OCUL Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for OCUL stands at 10.58. Similarly, the long-term debt-to-equity ratio is also 10.34.

OCUL Stock Stochastic Average

The raw stochastic average for Ocular Therapeutix Inc over the last 50 days is presently at 95.17%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 91.87%. Further, the company’s Stochastic %K and %D values for the last 20 days were 81.64% and 78.03%, respectively.

OCUL Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 27.35% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 45.64%. Over the past 30 days, the price of OCUL has fallen by 23.48%. And in the last five days, it has surged by 9.65%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts